Our model's win probability vs. the market's implied probability. The gap is the edge.
Every factor that moved the model. Every number sourced — no hallucinations.
The Braves open as -131 home chalk against the Mets in an NL East divisional matchup, and Supreme Brain's model assigns Atlanta a 63.0% win probability against a 50.0% market-implied probability at the current price. That 13-point gap translates to +5.0% expected value before vig (+1.8% after), enough to warrant a quarter-Kelly stake of 0.15 units. The edge hinges on home-field advantage in a rivalry context, though Atlanta carries 13 players on the injury report compared to nine for New York. The Mets have shown they can play up in Atlanta, which introduces meaningful variance. Still, a double-digit probability gap between model and market creates a high-conviction opportunity on the home side. The line reflects skepticism about Atlanta's depth; the model suggests that skepticism is overpriced.
Supreme Brain assigns the Braves a 63.0% win probability against the Mets at -131, a full 13 percentage points above the 50.0% market-implied probability. That gap is wide enough to generate +5.0% expected value before vig.
Atlanta offers a high-conviction play as home chalk in an NL East divisional game, with the model pricing the Braves 13 points more likely to win than the market does—enough edge to size a quarter-Kelly stake at 0.15 units.
The thesis breaks if the Mets' ability to play up in Atlanta—flagged explicitly by Supreme Brain—manifests in early scoring. New York has shown it can compete in this venue, and if the visitors jump ahead early, Atlanta's injury-depleted roster may lack the depth to mount a sustained comeback. A first-inning deficit of two or more runs would shift live probability enough to erase the pre-game edge.
The market sees a toss-up; the model sees a 63% favorite. That 13-point gap is the entire case, and it's enough.